Allogeneic Hematopoietic Cell Transplantation in Human Immunodeficiency Virus-Positive Patients with Hematologic Disorders: A Report from the Center for International Blood and Marrow Transplant Research

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 7, 2009, Pages 864-871

  Gupta, Vikas ^a   Tomblyn, Marcie ^b   Pedersen, Tanya L ^c   Atkins, Harry L ^d   Battiwalla, Minoo ^e   Gress, Ronald E ^f   Pollack, Marilyn S ^g   Storek, Jan ^h   Thompson, Jill C ^c   Tiberghien, Pierre ⁱ   Young, Jo Anne H ^b   Ribaud, Patricia ^j   Horowitz, Mary M ^k   Keating, Armand ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^c CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^d UNIVERSITY OF OTTAWA   (Canada)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g Mays Cancer Center at UT Health San Antonio   (United States)

^h UNIVERSITY OF CALGARY   (Canada)

ⁱ UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^j SAINT LOUIS HOSPITAL   (France)

^k MEDICAL COLLEGE OF WISCONSIN   (United States)

more..

Author keywords

Allogeneic; Bone marrow transplantation; Human immunodeficiency virus; Malignancy

Indexed keywords

ANTIRETROVIRUS AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIDANOSINE; METHOTREXATE; STAVUDINE; TACROLIMUS; ZIDOVUDINE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; ENGRAFTMENT; FEMALE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NONHODGKIN LYMPHOMA; RETROSPECTIVE STUDY; SURVIVAL RATE; THERAPY EFFECT; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHRONIC DISEASE; DISEASE-FREE SURVIVAL; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV SEROPOSITIVITY; HUMANS; MALE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 66949130694     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.03.023     Document Type: Article

References (35)

1. Bower M. Acquired immunodeficiency syndrome-related systemic non-Hodgkin's lymphoma. Br J Haematol 112 (2001) 863-873
2. Cooksley C.D., Hwang L.Y., Waller D.K., et al. HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS 10 (1999) 795-802
3. Grulich A.E., Wan X., Law M.G., et al. Risk of cancer in people with AIDS. AIDS 13 (1999) 839-843
4. Engels E.A., Biggar R.J., Hall H.I., et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 123 (2008) 187-194
5. Sutton L., Guenel P., Tanguy M.L., et al. Acute myeloid leukaemia in human immunodeficiency virus-infected adults: epidemiology, treatment feasibility and outcome. Br J Haematol 112 (2001) 900-908
6. Bonnet F., Lewden C., May T., et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 101 (2004) 317-324
7. Gabarre J., Azar N., Autran B., et al. High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma. Lancet 355 (2000) 1071-1072
8. Molina A., Krishnan A.Y., Nademanee A., et al. High-dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy. Cancer 89 (2000) 680-689
9. Krishnan A., Molina A., Zaia J., et al. Autologous stem cell transplantation for HIV-associated lymphoma. Blood 98 (2001) 3857-3859
10. Molina A., Zaia J., and Krishnan A. Treatment of human immunodeficiency virus-related lymphoma with haematopoietic stem cell transplantation. Blood Rev 17 (2003) 249-258
11. Re A., Cattaneo C., Michieli M., et al. High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 21 (2003) 4423-4427
12. Gabarre J., Marcelin A.G., Azar N., et al. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. Haematologica 89 (2004) 1100-1108
13. Krishnan A., Molina A., Zaia J., et al. Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood 105 (2005) 874-878
14. Serrano D., Carrion R., Balsalobre P., et al. HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation. Exp Hematol 33 (2005) 487-494
15. Fluri S., Ammann R., Lüthy A.R., et al. High-dose therapy and autologous stem cell transplantation for children with HIV-associated non-Hodgkin lymphoma. Pediatr Blood Cancer 49 7 (2007) 984-987
16. Hoffmann C., Repp R., Schoch R., et al. Successful autologous stem cell transplantation in a severely immunocompromised patient with relapsed AIDS-related B-cell lymphoma. Eur J Med Res 11 (2006) 73-76
17. Spitzer T.R., Ambinder R.F., Lee J.Y., et al. Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium Study 020. Biol Blood Marrow Transplant 14 (2008) 59-66
18. Cooper M.H., Maraninchi D., Gastaut J.A., et al. HIV infection in autologous and allogeneic bone marrow transplant patients: a retrospective analysis of the Marseille bone marrow transplant population. J Acquir Immune Defic Syndr 6 (1993) 277-284
19. Giri N., Vowels M.R., and Ziegler J.B. Failure of allogeneic bone marrow transplantation to benefit HIV infection. J Paediatr Child Health 28 (1992) 331-333
20. Torlontano G., Di Bartolomeo P., Di Girolamo G., et al. AIDS-related complex treated by antiviral drugs and allogeneic bone marrow transplantation following conditioning protocol with busulphan, cyclophosphamide and cyclosporin. Haematologica 77 (1992) 287-290
21. Tomonari A., Takahashi S., Shimohakamada Y., et al. Unrelated cord blood transplantation for a human immunodeficiency virus-1-seropositive patient with acute lymphoblastic leukemia. Bone Marrow Transplant 36 (2005) 261-262
22. + cell responses following allogeneic hematopoietic cell transplantation. Blood 112 (2008) 3484-3487
23. Wolf T., Rickerts V., Staszewski S., et al. First case of successful allogeneic stem cell transplantation in an HIV patient who acquired severe aplastic anemia. Haematologica 92 (2007) e56-e58
24. Kang E.M., de Witte M., Malech H., et al. Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome. Blood 99 (2002) 698-701
25. Sora F., Antinori A., Piccirillo N., et al. Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia. Exp Hematol 30 (2002) 279-284
26. Schlegel P., Beatty P., Halvorsen R., et al. Successful allogeneic bone marrow transplant in an HIV-1-positive man with chronic myelogenous leukemia. J Acquir Immune Defic Syndr 24 (2000) 289-290
27. Campbell P., Iland H., Gibson J., et al. Syngeneic stem cell transplantation for HIV-related lymphoma. Br J Haematol 105 (1999) 795-798
28. Bryant A., and Milliken S. Successful reduced-intensity conditioning allogeneic HSCT for HIV-related primary effusion lymphoma. Biol Blood Marrow Transplant 14 (2008) 601-602
29. Giralt S. Reduced-intensity conditioning regimens for hematologic malignancies: what have we learned over the last 10 years?. Hematology Am Soc Hematol Educ Program (2005) 384-389
30. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18 (1974) 295-304
31. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 69 (1980) 204-217
32. Geddes M., and Storek J. Immune reconstitution following hematopoietic stem cell transplantation. Best Pract Res Clin Haematol 20 (2007) 329-348
33. Abbott K.C., Swanson S.J., Agodoa L.Y., et al. Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression. J Am Soc Nephrol 15 (2004) 1633-1639
34. Qiu J., Terasaki P.I., Waki K., et al. HIV-positive renal recipients can achieve survival rates similar to those of HIV-negative patients. Transplantation 81 (2006) 1658-1661
35. Persad G.C., Little R.F., and Grady C. Including persons with HIV infection in cancer clinical trials. J Clin Oncol 26 (2008) 1027-1032